Annual Working Capital
$3.25 M
-$7.35 M-69.37%
June 30, 2024
Summary
- As of February 8, 2025, ANEB annual working capital is $3.25 million, with the most recent change of -$7.35 million (-69.37%) on June 30, 2024.
- During the last 3 years, ANEB annual working capital has fallen by -$18.16 million (-84.83%).
- ANEB annual working capital is now -84.83% below its all-time high of $21.41 million, reached on June 30, 2021.
Performance
ANEB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$1.39 M
-$1.85 M-57.09%
September 30, 2024
Summary
- As of February 8, 2025, ANEB quarterly working capital is $1.39 million, with the most recent change of -$1.85 million (-57.09%) on September 30, 2024.
- Over the past year, ANEB quarterly working capital has dropped by -$2.97 million (-68.05%).
- ANEB quarterly working capital is now -93.49% below its all-time high of $21.41 million, reached on June 30, 2021.
Performance
ANEB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ANEB Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.4% | -68.0% |
| 3 y3 years | -84.8% | -68.0% |
| 5 y5 years | +15.8% | -68.0% |
ANEB Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -84.8% | at low | -92.7% | at low |
| 5 y | 5-year | -84.8% | +15.8% | -93.5% | at low |
| alltime | all time | -84.8% | +15.8% | -93.5% | at low |
Anebulo Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.39 M(-57.1%) |
| Jun 2024 | $3.25 M(-69.4%) | $3.25 M(-25.5%) |
| Mar 2024 | - | $4.36 M(-24.9%) |
| Dec 2023 | - | $5.80 M(-30.4%) |
| Sep 2023 | - | $8.33 M(-21.4%) |
| Jun 2023 | $10.60 M | $10.60 M(-18.1%) |
| Mar 2023 | - | $12.94 M(-16.6%) |
| Dec 2022 | - | $15.52 M(-18.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $19.12 M(+26.9%) |
| Jun 2022 | $15.07 M(-29.6%) | $15.07 M(-12.2%) |
| Mar 2022 | - | $17.16 M(-9.3%) |
| Dec 2021 | - | $18.91 M(-4.9%) |
| Sep 2021 | - | $19.89 M(-7.1%) |
| Jun 2021 | $21.41 M(+663.5%) | $21.41 M(+493.9%) |
| Mar 2021 | - | $3.61 M(+67.3%) |
| Dec 2020 | - | $2.16 M |
| Jun 2020 | $2.80 M | - |
FAQ
- What is Anebulo Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals annual working capital year-on-year change?
- What is Anebulo Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals quarterly working capital year-on-year change?
What is Anebulo Pharmaceuticals annual working capital?
The current annual working capital of ANEB is $3.25 M
What is the all time high annual working capital for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high annual working capital is $21.41 M
What is Anebulo Pharmaceuticals annual working capital year-on-year change?
Over the past year, ANEB annual working capital has changed by -$7.35 M (-69.37%)
What is Anebulo Pharmaceuticals quarterly working capital?
The current quarterly working capital of ANEB is $1.39 M
What is the all time high quarterly working capital for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high quarterly working capital is $21.41 M
What is Anebulo Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ANEB quarterly working capital has changed by -$2.97 M (-68.05%)